The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Allarity Therapeutics, Inc.(NASDAQ:ALLR) 
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is i...
Website: https://www.allarity.com
Founded: 2004
Full Time Employees: 13
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Allarity Therapeutics . Days Payable Outstanding ttm (DPO)
Allarity Therapeutics . Days Inventory Outstanding ttm (DIO)
Allarity Therapeutics . Op Cashflow Per Share ttm
Allarity Therapeutics . Free Cashflow Per Share ttm
Allarity Therapeutics . Cash Per Share ttm
Allarity Therapeutics . (GAAP) P/E ratio ttm
Allarity Therapeutics . P/B ratio ttm
No extra charts and metrics for this ticker.